XML 45 R2.htm IDEA: XBRL DOCUMENT
v3.25.1

Pay vs Performance Disclosure | 12 Months Ended
--- | ---
Dec. 31, 2024 USD ($) $ / shares | Dec. 31, 2023 USD ($) $ / shares | Dec. 31, 2022 USD ($) $ / shares | Dec. 31, 2021 USD ($) $ / shares | Dec. 31, 2020 USD ($) $ / shares
Pay vs Performance Disclosure |  |  |  |  |
Pay vs Performance Disclosure, Table | Pay vs. Performance The disclosure included in this section is prescribed by SEC rules and is not incorporated by reference to Part III of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. The Compensation and Human Resources Committee did not consider the pay versus performance data presented below in making its pay decisions for any of the years shown. As described in greater detail above in the “Compensation Discussion and Analysis” section, our executive compensation program strongly links executive pay and the achievement of enterprise goals, which are aligned to the economic interests of our shareholders. This strong pay-for-performance linkage is a core principle of our executive compensation philosophy, with a large majority of executive officers’ compensation at risk and weighted towards long-term compensation to promote long-term shareholder value creation. Approximately 78% of total compensation granted to the named executive offers in 2024 was stock-based long-term compensation that is earned over multiple years only if the company and stock perform for shareholders. The robust oversight and governance practices discourage excessive or unnecessary risk-taking and include a balanced set of performance measures with different metrics used for the annual and long-term incentive plans. The stock retention policy requires executive officers to hold, for at least one year, one-third of the net shares acquired upon vesting or exercise of any stock compensation award. For example, an executive exercising options which had been held for ten years is required to retain one-third of the net shares acquired for an additional year. In addition, compensation clawback policies allow, and in some cases require, the Board to seek cash or stock compensation reimbursement from senior executives in certain circumstances, including specified situations involving financial restatements, material detrimental conduct, or violation of non-compete, non-solicit or confidentiality provisions. The following table sets forth information concerning the compensation imputed to the current and former Principal Executive Officers (each, a PEO) and to the other Named Executive Officers (NEOs) compared to certain performance measures for the years ended December 31, 2024, 2023, 2022, 2021, and 2020.
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Value of Initial Fixed $100 Investment Based on: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | Year | ​ | ​ | Summary Compensation Table Total for Current PEO(2)(4) | ​ | ​ | Summary Compensation Table Total for Former PEO(2)(4) | ​ | ​ | Compensation Actually Paid Current PEO(1)(2)(5)(6) | ​ | ​ | Compensation Actually Paid Former PEO(1)(2)(5)(6) | ​ | ​ | Average Summary Compensation Table Total for Non-PEO Named Executive Officers(3)(4) | ​ | ​ | Average Compensation Actually Paid Non-PEO Named Executive Officers(1)(3)(5)(6) | ​ | ​ | TSR | ​ | ​ | Peer Group TSR (S&P 500 Health Care Index)(7) | ​ | ​ | Net Income | ​ | ​ | Adjusted EPS(8) | ​
​ | 2024 | ​ | ​ | ​ | $ | 26,339,215 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | 24,226,014 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | 10,461,579 | ​ | ​ | ​ | ​ | $ | 10,583,224 | ​ | ​ | ​ | ​ | $ | 185 | ​ | ​ | ​ | ​ | $ | 147 | ​ | ​ | ​ | ​ | $ | 15,242,000,000 | ​ | ​ | ​ | ​ | $ | 27.66 | ​ | ​
​ | 2023 | ​ | ​ | ​ | $ | 23,534,936 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | 20,178,170 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | 12,198,157 | ​ | ​ | ​ | ​ | $ | 10,383,382 | ​ | ​ | ​ | ​ | $ | 190 | ​ | ​ | ​ | ​ | $ | 143 | ​ | ​ | ​ | ​ | $ | 23,144,000,000 | ​ | ​ | ​ | ​ | $ | 25.12 | ​ | ​
​ | 2022 | ​ | ​ | ​ | $ | 20,865,106 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | 31,259,796 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | 13,210,724 | ​ | ​ | ​ | ​ | $ | 17,698,638 | ​ | ​ | ​ | ​ | $ | 188 | ​ | ​ | ​ | ​ | $ | 140 | ​ | ​ | ​ | ​ | $ | 20,639,000,000 | ​ | ​ | ​ | ​ | $ | 22.19 | ​ | ​
​ | 2021 | ​ | ​ | ​ | $ | 18,433,143 | ​ | ​ | ​ | ​ | $ | 11,221,093 | ​ | ​ | ​ | ​ | $ | 55,452,750 | ​ | ​ | ​ | ​ | $ | 36,611,403 | ​ | ​ | ​ | ​ | $ | 11,347,389 | ​ | ​ | ​ | ​ | $ | 29,088,841 | ​ | ​ | ​ | ​ | $ | 176 | ​ | ​ | ​ | ​ | $ | 143 | ​ | ​ | ​ | ​ | $ | 17,732,000,000 | ​ | ​ | ​ | ​ | $ | 19.02 | ​ | ​
​ | 2020 | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | 17,872,713 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | 37,166,242 | ​ | ​ | ​ | ​ | $ | 11,312,854 | ​ | ​ | ​ | ​ | $ | 19,941,168 | ​ | ​ | ​ | ​ | $ | 121 | ​ | ​ | ​ | ​ | $ | 113 | ​ | ​ | ​ | ​ | $ | 15,769,000,000 | ​ | ​ | ​ | ​ | $ | 16.88 | ​ | ​
​ (1) The term compensation actually paid is a mandated SEC naming convention, and the methodology for calculating compensation actually paid also is mandated by the SEC rule. The amount shown for any period, however, does not reflect total compensation actually earned during the period. Instead, the amounts shown reflect, among other things, adjustments to the grant date fair value of stock compensation awards reported in the Summary Compensation Table to reflect their fair value as of the last day of the fiscal year and increases or decreases in the value of unvested stock compensation awards granted in prior years, which may never actually vest or may have a different value when they do vest. Accordingly, these totals change from year to year based primarily upon share performance, but do not reflect actual compensation paid or earned by an executive for any year. Compensation resulting from an award of options is not actually realized until exercise, which vest over 4 years and have a 10-year duration; vesting of RSUs which vest ratably over 4 years; or completion and achievement of a long-term performance share plan, which has a 3-year duration. See footnote 5 below for a more detailed break down between earned/vested and unearned/unvested amounts. (2) Andrew has served as PEO since February 3, 2021. Dave Wichmann, the former PEO served until February 2, 2021. These columns reflect amounts for both PEOs in 2021 when both served as PEO for a portion of the year. ​ (3) For 2024, the other NEOs were John, Heather, Chris, Erin and Brian. For 2022 and 2023, the other NEOs were John, Dirk McMahon, Brian and Rupert Bondy. For 2021, the other NEOs were John, Dirk, Brian and Marianne Short. For 2020, the other NEOs were John, Andrew, Dirk and Patricia Lewis. ​ (4) The values reflected in this column reflect the Total compensation set forth in the Summary Compensation Table (SCT) on page 48. See the footnotes to the SCT for further detail regarding the amounts in these columns. ​ (5) In accordance with SEC rules, the Compensation Actually Paid (CAP) totals reflected in these columns is computed by deducting and adding the following amounts from the Total column of the SCT (fair value at each measurement date is computed in a manner consistent with the fair value methodology used to account for share-based payments in our financial statements under GAAP). The change in value from the SCT to CAP is based on the change in fair value of outstanding long-term incentive awards which is primarily driven by changes in our share price and company performance between measurement dates: ​
​ | 2024 | ​ | ​ | Current PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 26,339,215 | ​ | ​ | ​ | ​ | $ | 10,461,579 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (23,000,118) | ​ | ​ | ​ | ​ | $ | (8,100,932) | ​ | ​
​ | Add Fair Value of Awards Granted in 2024 (Unvested / Unearned) as of 12/31/24 | ​ | ​ | ​ | $ | 21,201,523 | ​ | ​ | ​ | ​ | $ | 6,934,188 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/24 | ​ | ​ | ​ | $ | (2,389,054) | ​ | ​ | ​ | ​ | $ | (407,853) | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2024 as of the Vesting Date | ​ | ​ | ​ | $ | 2,074,448 | ​ | ​ | ​ | ​ | $ | 1,696,242 | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 24,226,014 | ​ | ​ | ​ | ​ | $ | 10,583,224 | ​ | ​
​ | 2023 | ​ | ​ | Current PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 23,534,936 | ​ | ​ | ​ | ​ | $ | 12,198,157 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (20,001,084) | ​ | ​ | ​ | ​ | $ | (9,825,797) | ​ | ​
​ | Add Fair Value of Awards Granted in 2023 (Unvested / Unearned) as of 12/31/23 | ​ | ​ | ​ | $ | 20,931,590 | ​ | ​ | ​ | ​ | $ | 10,203,134 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/23 | ​ | ​ | ​ | $ | (2,051,233) | ​ | ​ | ​ | ​ | $ | (1,122,439) | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2023 as of the Vesting Date | ​ | ​ | ​ | $ | (2,236,039) | ​ | ​ | ​ | ​ | $ | (1,069,673) | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 20,178,170 | ​ | ​ | ​ | ​ | $ | 10,383,382 | ​ | ​
​ | 2022 | ​ | ​ | Current PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 20,865,106 | ​ | ​ | ​ | ​ | $ | 13,210,724 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (16,500,772) | ​ | ​ | ​ | ​ | $ | (9,700,891) | ​ | ​
​ | Add Fair Value of Awards Granted in 2022 (Unvested / Unearned) as of 12/31/22 | ​ | ​ | ​ | $ | 19,765,736 | ​ | ​ | ​ | ​ | $ | 11,470,624 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/22 | ​ | ​ | ​ | $ | 4,501,423 | ​ | ​ | ​ | ​ | $ | 2,159,448 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2022 as of the Vesting Date | ​ | ​ | ​ | $ | 2,628,303 | ​ | ​ | ​ | ​ | $ | 558,733 | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 31,259,796 | ​ | ​ | ​ | ​ | $ | 17,698,638 | ​ | ​
​ | 2021 | ​ | ​ | Current PEO | ​ | ​ | Former PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 18,433,143 | ​ | ​ | ​ | ​ | $ | 11,221,093 | ​ | ​ | ​ | ​ | $ | 11,347,389 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (14,375,350) | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | (8,575,523) | ​ | ​
​ | Add Fair Value of Awards Granted in 2021 (Unvested / Unearned) as of 12/31/21 | ​ | ​ | ​ | $ | 24,998,702 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | 14,389,137 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/21 | ​ | ​ | ​ | $ | 22,167,623 | ​ | ​ | ​ | ​ | $ | 22,084,683 | ​ | ​ | ​ | ​ | $ | 10,877,212 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2021 as of the Vesting Date | ​ | ​ | ​ | $ | 4,228,632 | ​ | ​ | ​ | ​ | $ | 3,305,627 | ​ | ​ | ​ | ​ | $ | 1,050,626 | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 55,452,750 | ​ | ​ | ​ | ​ | $ | 36,611,403 | ​ | ​ | ​ | ​ | $ | 29,088,841 | ​ | ​
​ | 2020 | ​ | ​ | Former PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 17,872,713 | ​ | ​ | ​ | ​ | $ | 11,312,854 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (12,800,630) | ​ | ​ | ​ | ​ | $ | (8,050,262) | ​ | ​
​ | Add Fair Value of Awards Granted in 2020 (Unvested / Unearned) as of 12/31/20 | ​ | ​ | ​ | $ | 16,861,629 | ​ | ​ | ​ | ​ | $ | 10,678,145 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/20 | ​ | ​ | ​ | $ | 9,852,819 | ​ | ​ | ​ | ​ | $ | 4,699,669 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2020 as of the Vesting Date | ​ | ​ | ​ | $ | 5,379,711 | ​ | ​ | ​ | ​ | $ | 1,300,762 | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 37,166,242 | ​ | ​ | ​ | ​ | $ | 19,941,168 | ​ | ​
​ (6) The methodology used to determine the fair value of long-term incentive awards at each measurement date for purposes of the SEC pay versus performance disclosure rules is consistent with the methodology used to calculate the grant date fair value of these same awards for purposes of SCT Total Compensation. The inclusion of long-term incentive awards granted in prior years and the change in our stock price at each measurement date (and the resulting impact on the fair value calculation) is the most significant factor in the difference between the reported ​ SCT Total Compensation and the determination of compensation amounts attributable in determining CAP for each reporting year under the SEC pay versus performance rules. (7) Reflects our cumulative TSR and the cumulative TSR of the S&P 500 Health Care Index for the year ended December 31, 2020, the two-years ended December 31, 2021, the three years ended December 31, 2022, the four years ended December 31, 2023, and the five years ended December 31, 2024, assuming a $100 investment at the closing price on December 31, 2019 and the reinvestment of all dividends. ​ (8) Performance shares granted under the long-term incentive plan, which are selected to ensure a strong pay-for-performance alignment between the Company’s executive compensation program and drivers of shareholder value, account for 44% and 38% of overall compensation respectively to the PEO and non-PEO NEOs during the most recently completed fiscal year and are weighted equally between cumulative adjusted EPS and average return on equity for the three-year performance period. Cumulative adjusted EPS includes the adjusted EPS for each year of the three-year performance period. Refer to Appendix A for a description of how adjusted EPS is calculated from the Company’s financial statements and the section entitled “Long-Term Awards” in the “Compensation Discussion and Analysis” section of this proxy statement for additional information related to the adjusted EPS performance measure within our long-term performance share awards. The correlation and impact of operating income (a performance measure described in more detail in our discussion of our annual incentive plan in the “Compensation Discussion and Analysis” section above) on adjusted EPS is the reason we selected adjusted EPS for inclusion in our Pay Versus Performance table as opposed to the return on equity metric. |  |  |  |
Company Selected Measure Name | Adjusted EPS |  |  |  |
Named Executive Officers, Footnote | (2) Andrew has served as PEO since February 3, 2021. Dave Wichmann, the former PEO served until February 2, 2021. These columns reflect amounts for both PEOs in 2021 when both served as PEO for a portion of the year. ​ (3) For 2024, the other NEOs were John, Heather, Chris, Erin and Brian. For 2022 and 2023, the other NEOs were John, Dirk McMahon, Brian and Rupert Bondy. For 2021, the other NEOs were John, Dirk, Brian and Marianne Short. For 2020, the other NEOs were John, Andrew, Dirk and Patricia Lewis. |  |  |  |
Peer Group Issuers, Footnote | (7) Reflects our cumulative TSR and the cumulative TSR of the S&P 500 Health Care Index for the year ended December 31, 2020, the two-years ended December 31, 2021, the three years ended December 31, 2022, the four years ended December 31, 2023, and the five years ended December 31, 2024, assuming a $100 investment at the closing price on December 31, 2019 and the reinvestment of all dividends. |  |  |  |
Adjustment To PEO Compensation, Footnote | (4) The values reflected in this column reflect the Total compensation set forth in the Summary Compensation Table (SCT) on page 48. See the footnotes to the SCT for further detail regarding the amounts in these columns. ​ (5) In accordance with SEC rules, the Compensation Actually Paid (CAP) totals reflected in these columns is computed by deducting and adding the following amounts from the Total column of the SCT (fair value at each measurement date is computed in a manner consistent with the fair value methodology used to account for share-based payments in our financial statements under GAAP). The change in value from the SCT to CAP is based on the change in fair value of outstanding long-term incentive awards which is primarily driven by changes in our share price and company performance between measurement dates: ​
​ | 2024 | ​ | ​ | Current PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 26,339,215 | ​ | ​ | ​ | ​ | $ | 10,461,579 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (23,000,118) | ​ | ​ | ​ | ​ | $ | (8,100,932) | ​ | ​
​ | Add Fair Value of Awards Granted in 2024 (Unvested / Unearned) as of 12/31/24 | ​ | ​ | ​ | $ | 21,201,523 | ​ | ​ | ​ | ​ | $ | 6,934,188 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/24 | ​ | ​ | ​ | $ | (2,389,054) | ​ | ​ | ​ | ​ | $ | (407,853) | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2024 as of the Vesting Date | ​ | ​ | ​ | $ | 2,074,448 | ​ | ​ | ​ | ​ | $ | 1,696,242 | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 24,226,014 | ​ | ​ | ​ | ​ | $ | 10,583,224 | ​ | ​
​ | 2023 | ​ | ​ | Current PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 23,534,936 | ​ | ​ | ​ | ​ | $ | 12,198,157 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (20,001,084) | ​ | ​ | ​ | ​ | $ | (9,825,797) | ​ | ​
​ | Add Fair Value of Awards Granted in 2023 (Unvested / Unearned) as of 12/31/23 | ​ | ​ | ​ | $ | 20,931,590 | ​ | ​ | ​ | ​ | $ | 10,203,134 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/23 | ​ | ​ | ​ | $ | (2,051,233) | ​ | ​ | ​ | ​ | $ | (1,122,439) | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2023 as of the Vesting Date | ​ | ​ | ​ | $ | (2,236,039) | ​ | ​ | ​ | ​ | $ | (1,069,673) | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 20,178,170 | ​ | ​ | ​ | ​ | $ | 10,383,382 | ​ | ​
​ | 2022 | ​ | ​ | Current PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 20,865,106 | ​ | ​ | ​ | ​ | $ | 13,210,724 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (16,500,772) | ​ | ​ | ​ | ​ | $ | (9,700,891) | ​ | ​
​ | Add Fair Value of Awards Granted in 2022 (Unvested / Unearned) as of 12/31/22 | ​ | ​ | ​ | $ | 19,765,736 | ​ | ​ | ​ | ​ | $ | 11,470,624 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/22 | ​ | ​ | ​ | $ | 4,501,423 | ​ | ​ | ​ | ​ | $ | 2,159,448 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2022 as of the Vesting Date | ​ | ​ | ​ | $ | 2,628,303 | ​ | ​ | ​ | ​ | $ | 558,733 | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 31,259,796 | ​ | ​ | ​ | ​ | $ | 17,698,638 | ​ | ​
​ | 2021 | ​ | ​ | Current PEO | ​ | ​ | Former PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 18,433,143 | ​ | ​ | ​ | ​ | $ | 11,221,093 | ​ | ​ | ​ | ​ | $ | 11,347,389 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (14,375,350) | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | (8,575,523) | ​ | ​
​ | Add Fair Value of Awards Granted in 2021 (Unvested / Unearned) as of 12/31/21 | ​ | ​ | ​ | $ | 24,998,702 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | 14,389,137 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/21 | ​ | ​ | ​ | $ | 22,167,623 | ​ | ​ | ​ | ​ | $ | 22,084,683 | ​ | ​ | ​ | ​ | $ | 10,877,212 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2021 as of the Vesting Date | ​ | ​ | ​ | $ | 4,228,632 | ​ | ​ | ​ | ​ | $ | 3,305,627 | ​ | ​ | ​ | ​ | $ | 1,050,626 | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 55,452,750 | ​ | ​ | ​ | ​ | $ | 36,611,403 | ​ | ​ | ​ | ​ | $ | 29,088,841 | ​ | ​
​ | 2020 | ​ | ​ | Former PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 17,872,713 | ​ | ​ | ​ | ​ | $ | 11,312,854 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (12,800,630) | ​ | ​ | ​ | ​ | $ | (8,050,262) | ​ | ​
​ | Add Fair Value of Awards Granted in 2020 (Unvested / Unearned) as of 12/31/20 | ​ | ​ | ​ | $ | 16,861,629 | ​ | ​ | ​ | ​ | $ | 10,678,145 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/20 | ​ | ​ | ​ | $ | 9,852,819 | ​ | ​ | ​ | ​ | $ | 4,699,669 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2020 as of the Vesting Date | ​ | ​ | ​ | $ | 5,379,711 | ​ | ​ | ​ | ​ | $ | 1,300,762 | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 37,166,242 | ​ | ​ | ​ | ​ | $ | 19,941,168 | ​ | ​
Non-PEO NEO Average Total Compensation Amount | $ 10,461,579 | $ 12,198,157 | $ 13,210,724 | $ 11,347,389 | $ 11,312,854
Non-PEO NEO Average Compensation Actually Paid Amount | $ 10,583,224 | 10,383,382 | 17,698,638 | 29,088,841 | 19,941,168
Adjustment to Non-PEO NEO Compensation Footnote | (4) The values reflected in this column reflect the Total compensation set forth in the Summary Compensation Table (SCT) on page 48. See the footnotes to the SCT for further detail regarding the amounts in these columns. ​ (5) In accordance with SEC rules, the Compensation Actually Paid (CAP) totals reflected in these columns is computed by deducting and adding the following amounts from the Total column of the SCT (fair value at each measurement date is computed in a manner consistent with the fair value methodology used to account for share-based payments in our financial statements under GAAP). The change in value from the SCT to CAP is based on the change in fair value of outstanding long-term incentive awards which is primarily driven by changes in our share price and company performance between measurement dates: ​
​ | 2024 | ​ | ​ | Current PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 26,339,215 | ​ | ​ | ​ | ​ | $ | 10,461,579 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (23,000,118) | ​ | ​ | ​ | ​ | $ | (8,100,932) | ​ | ​
​ | Add Fair Value of Awards Granted in 2024 (Unvested / Unearned) as of 12/31/24 | ​ | ​ | ​ | $ | 21,201,523 | ​ | ​ | ​ | ​ | $ | 6,934,188 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/24 | ​ | ​ | ​ | $ | (2,389,054) | ​ | ​ | ​ | ​ | $ | (407,853) | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2024 as of the Vesting Date | ​ | ​ | ​ | $ | 2,074,448 | ​ | ​ | ​ | ​ | $ | 1,696,242 | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 24,226,014 | ​ | ​ | ​ | ​ | $ | 10,583,224 | ​ | ​
​ | 2023 | ​ | ​ | Current PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 23,534,936 | ​ | ​ | ​ | ​ | $ | 12,198,157 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (20,001,084) | ​ | ​ | ​ | ​ | $ | (9,825,797) | ​ | ​
​ | Add Fair Value of Awards Granted in 2023 (Unvested / Unearned) as of 12/31/23 | ​ | ​ | ​ | $ | 20,931,590 | ​ | ​ | ​ | ​ | $ | 10,203,134 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/23 | ​ | ​ | ​ | $ | (2,051,233) | ​ | ​ | ​ | ​ | $ | (1,122,439) | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2023 as of the Vesting Date | ​ | ​ | ​ | $ | (2,236,039) | ​ | ​ | ​ | ​ | $ | (1,069,673) | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 20,178,170 | ​ | ​ | ​ | ​ | $ | 10,383,382 | ​ | ​
​ | 2022 | ​ | ​ | Current PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 20,865,106 | ​ | ​ | ​ | ​ | $ | 13,210,724 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (16,500,772) | ​ | ​ | ​ | ​ | $ | (9,700,891) | ​ | ​
​ | Add Fair Value of Awards Granted in 2022 (Unvested / Unearned) as of 12/31/22 | ​ | ​ | ​ | $ | 19,765,736 | ​ | ​ | ​ | ​ | $ | 11,470,624 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/22 | ​ | ​ | ​ | $ | 4,501,423 | ​ | ​ | ​ | ​ | $ | 2,159,448 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2022 as of the Vesting Date | ​ | ​ | ​ | $ | 2,628,303 | ​ | ​ | ​ | ​ | $ | 558,733 | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 31,259,796 | ​ | ​ | ​ | ​ | $ | 17,698,638 | ​ | ​
​ | 2021 | ​ | ​ | Current PEO | ​ | ​ | Former PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 18,433,143 | ​ | ​ | ​ | ​ | $ | 11,221,093 | ​ | ​ | ​ | ​ | $ | 11,347,389 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (14,375,350) | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | (8,575,523) | ​ | ​
​ | Add Fair Value of Awards Granted in 2021 (Unvested / Unearned) as of 12/31/21 | ​ | ​ | ​ | $ | 24,998,702 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | $ | 14,389,137 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/21 | ​ | ​ | ​ | $ | 22,167,623 | ​ | ​ | ​ | ​ | $ | 22,084,683 | ​ | ​ | ​ | ​ | $ | 10,877,212 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2021 as of the Vesting Date | ​ | ​ | ​ | $ | 4,228,632 | ​ | ​ | ​ | ​ | $ | 3,305,627 | ​ | ​ | ​ | ​ | $ | 1,050,626 | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 55,452,750 | ​ | ​ | ​ | ​ | $ | 36,611,403 | ​ | ​ | ​ | ​ | $ | 29,088,841 | ​ | ​
​ | 2020 | ​ | ​ | Former PEO | ​ | ​ | Non-PEO NEOs | ​
​ | SCT Total Compensation | ​ | ​ | ​ | $ | 17,872,713 | ​ | ​ | ​ | ​ | $ | 11,312,854 | ​ | ​
​ | Deduct Grant Date Fair Value of Stock Awards and Option Awards (as disclosed in the SCT) | ​ | ​ | ​ | $ | (12,800,630) | ​ | ​ | ​ | ​ | $ | (8,050,262) | ​ | ​
​ | Add Fair Value of Awards Granted in 2020 (Unvested / Unearned) as of 12/31/20 | ​ | ​ | ​ | $ | 16,861,629 | ​ | ​ | ​ | ​ | $ | 10,678,145 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years (Unvested / Unearned) as of 12/31/20 | ​ | ​ | ​ | $ | 9,852,819 | ​ | ​ | ​ | ​ | $ | 4,699,669 | ​ | ​
​ | Add Change in Fair Value of Awards Granted in Prior Years that Vested during 2020 as of the Vesting Date | ​ | ​ | ​ | $ | 5,379,711 | ​ | ​ | ​ | ​ | $ | 1,300,762 | ​ | ​
​ | CAP Total | ​ | ​ | ​ | $ | 37,166,242 | ​ | ​ | ​ | ​ | $ | 19,941,168 | ​ | ​
Tabular List, Table | Most Important Performance Measures. The most important performance measures we use in setting pay-for-performance compensation for the most recently completed fiscal year are listed alphabetically in the table below. The manner in which these measures determine the amounts of incentive compensation paid to NEOs is described above in the “Compensation Discussion and Analysis” section of this proxy statement.
​ | Most Important Performance Measures | ​
​ | Adjusted Earnings Per Share (EPS) | ​
​ | Cash Flow from Operations | ​
​ | Employee Experience Index (EXI) | ​
​ | Operating Income | ​
​ | Net Promoter System (NPS) | ​
​ | Return on Equity | ​
​ | Revenue | ​
Total Shareholder Return Amount | $ 185 | 190 | 188 | 176 | 121
Peer Group Total Shareholder Return Amount | $ 147 | $ 143 | $ 140 | $ 143 | $ 113
Company Selected Measure Amount | $ / shares | 27.66 | 25.12 | 22.19 | 19.02 | 16.88
PEO Name | Andrew |  |  |  |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $ 15,242,000,000 | $ 23,144,000,000 | $ 20,639,000,000 | $ 17,732,000,000 | $ 15,769,000,000
Measure:: 1 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Adjusted Earnings Per Share (EPS) |  |  |  |
Non-GAAP Measure Description | (8) Performance shares granted under the long-term incentive plan, which are selected to ensure a strong pay-for-performance alignment between the Company’s executive compensation program and drivers of shareholder value, account for 44% and 38% of overall compensation respectively to the PEO and non-PEO NEOs during the most recently completed fiscal year and are weighted equally between cumulative adjusted EPS and average return on equity for the three-year performance period. Cumulative adjusted EPS includes the adjusted EPS for each year of the three-year performance period. Refer to Appendix A for a description of how adjusted EPS is calculated from the Company’s financial statements and the section entitled “Long-Term Awards” in the “Compensation Discussion and Analysis” section of this proxy statement for additional information related to the adjusted EPS performance measure within our long-term performance share awards. The correlation and impact of operating income (a performance measure described in more detail in our discussion of our annual incentive plan in the “Compensation Discussion and Analysis” section above) on adjusted EPS is the reason we selected adjusted EPS for inclusion in our Pay Versus Performance table as opposed to the return on equity metric. |  |  |  |
Measure:: 2 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Cash Flow from Operations |  |  |  |
Measure:: 3 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Employee Experience Index (EXI) |  |  |  |
Measure:: 4 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Operating Income |  |  |  |
Measure:: 5 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Net Promoter System (NPS) |  |  |  |
Measure:: 6 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Return on Equity |  |  |  |
Measure:: 7 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Revenue |  |  |  |
Andrew Witty [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
PEO Total Compensation Amount | $ 26,339,215 | 23,534,936 | 20,865,106 | 18,433,143 |
PEO Actually Paid Compensation Amount | 24,226,014 | 20,178,170 | 31,259,796 | 55,452,750 |
Dave Wichmann [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
PEO Total Compensation Amount |  |  |  | 11,221,093 | 17,872,713
PEO Actually Paid Compensation Amount |  |  |  | 36,611,403 | 37,166,242
Non-PEO NEO Average Total Compensation Amount |  |  |  |  |
PEO [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Performance Shares Granted As A Percentage Of Overall Compensation To PEO | 44.00% |  |  |  |
PEO [Member] | Andrew Witty [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | $ (23,000,118) | (20,001,084) | (16,500,772) | (14,375,350) |
PEO [Member] | Andrew Witty [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 21,201,523 | 20,931,590 | 19,765,736 | 24,998,702 |
PEO [Member] | Andrew Witty [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (2,389,054) | (2,051,233) | 4,501,423 | 22,167,623 |
PEO [Member] | Andrew Witty [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | $ 2,074,448 | (2,236,039) | 2,628,303 | 4,228,632 |
PEO [Member] | Dave Wichmann [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount |  |  |  |  | (12,800,630)
PEO [Member] | Dave Wichmann [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount |  |  |  |  | 16,861,629
PEO [Member] | Dave Wichmann [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount |  |  |  | 22,084,683 | 9,852,819
PEO [Member] | Dave Wichmann [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount |  |  |  | 3,305,627 | 5,379,711
Non-PEO NEO [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Performance Shares Granted As A Percentage Of Overall Compensation To NEOs | 38.00% |  |  |  |
Non-PEO NEO [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | $ (8,100,932) | (9,825,797) | (9,700,891) | (8,575,523) | (8,050,262)
Non-PEO NEO [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 6,934,188 | 10,203,134 | 11,470,624 | 14,389,137 | 10,678,145
Non-PEO NEO [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (407,853) | (1,122,439) | 2,159,448 | 10,877,212 | 4,699,669
Non-PEO NEO [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | $ 1,696,242 | $ (1,069,673) | $ 558,733 | $ 1,050,626 | $ 1,300,762

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToPeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_MeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_NonGaapMeasureDescriptionTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupIssuersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupTotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_PeoActuallyPaidCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_PeoName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_PeoTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 6 + Details
Name: | ecd_TabularListTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents information pertaining to performance shares granted as a percentage of overall compensation to NEOs. + References No definition available. + Details
Name: | unh_PerformanceSharesGrantedAsAPercentageOfOverallCompensationToNEOs
Namespace Prefix: | unh_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | unh_PerformanceSharesGrantedAsAPercentageOfOverallCompensationToPEO
Namespace Prefix: | unh_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 205 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(16)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 19 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19 Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-05(b)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7 Reference 31: http://www.xbrl.org/2003/role/exampleRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 4J -Publisher FASB -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J Reference 32: http://www.xbrl.org/2003/role/exampleRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 4K -Publisher FASB -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2 Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A Reference 37: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A + Details
Name: | us-gaap_ProfitLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ecd_MeasureAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=4
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=5
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=6
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=7
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=unh_AndrewWittyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=unh_DaveWichmannMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |